Garlic and heart disease

Journal of Nutrition

Volumn 146, Issue 2, 2016, Pages 416S-421S

  Varshney, Ravi ^a   Budoff, Matthew J ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Cholesterol; Garlic; Heart disease; Hypertension; Treatment

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GARLIC EXTRACT; GARLIC OIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; WARFARIN; PLANT EXTRACT;

ABDOMINAL PAIN; ADIPOSE TISSUE; ALLERGIC ASTHMA; ALLERGIC REACTION; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL STIFFNESS; ARTICLE; ATHEROSCLEROSIS; BLEEDING; BLOATING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; DATA EXTRACTION; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DYSLIPIDEMIA; DYSPHAGIA; EPICARDIUM; ESOPHAGITIS; FLATULENCE; FOOD SAFETY; FRAMINGHAM RISK SCORE; GARLIC; HALITOSIS; HEART DISEASE; HEART INFARCTION; HEMATEMESIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDICAL LITERATURE; MEDICAL SUBJECT HEADINGS; MEDLINE; META ANALYSIS (TOPIC); PEMPHIGUS; PHOTOALLERGY; POSTOPERATIVE HEMORRHAGE; PROTECTION; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM HEMORRHAGE; RETROBULBAR HEMORRHAGE; RISK REDUCTION; SIDE EFFECT; SKIN ALLERGY; SMALL INTESTINE OBSTRUCTION; SPINAL HEMATOMA; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; URTICARIA; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; DRUG EFFECTS; HEART DISEASES; PHYTOTHERAPY;

ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIETARY SUPPLEMENTS; GARLIC; HEART DISEASES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84959299785     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.202333     Document Type: Article

References (56)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
2. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000;102:1511-6.
3. Zeng T, Zhang CL, Zhao XL, Xie KQ. The roles of garlic on the lipid parameters: a systematic review of the literature. Crit Rev Food Sci Nutr 2013;53:215-30.
4. Ernst E. Mol Nutr Food Res 2007;51:1317.
5. Gorinstein S, Jastrzebski Z, Namiesnik J, Leontowicz H, Leontowicz M, Trakhtenberg S. The atherosclerotic heart disease and protecting properties of garlic: contemporary data. Mol Nutr Food Res 2007; 51:1365-81.
6. Svechnikov VA. [Mechanism of action of garlic on the heart and on the blood vessels] Tr Leningr Sanitarnogig Med Inst 1957;34:189-92 (In Russian).
7. Stabler SN, Tejani AM, Huynh F, Fowkes C. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients. Cochrane Database Syst Rev 2012;8:CD007653.
8. El-Sabban F, Abouazra H. Effect of garlic on atherosclerosis and its factors. East Mediterr Health J 2008;14:195-205.
9. Wolsko PM, Solondz DK, Phillips RS, Schachter SC, Eisenberg DM. Lack of herbal supplement characterization in published randomized controlled trials. Am J Med 2005;118:1087-93.
10. Alder R, Lookinland S, Berry JA, Williams M. A systematic review of the effectiveness of garlic as an anti-hyperlipidemic agent. J Am Acad Nurse Pract 2003;15:120-9.
11. Simons S, Wollersheim H, Thien T. A systematic review on the influence of trial quality on the effect of garlic on blood pressure. Neth J Med 2009;67:212-9.
12. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008;336:1121-3.
13. Osamor PE, Owumi BE. Complementary and alternative medicine in the management of hypertension in an urban Nigerian community. BMC Complement Altern Med 2010;10:36-40.
14. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994;12:463-8.
15. Reinhart KM, Coleman CI, Teevan C, Vachhani P, White M. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother 2008;42:1766-71.
16. Ried K, Fran OR, Stocks NP, Fakler P, Sullivan T. Effects of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord 2008;8:13.
17. Ried K, Frank OR, Stocks NP. Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial. Eur J Clin Nutr 2013;67:64-70.
18. Nakasone Y, Nakamura Y, Yamamoto T, Yamaguchi H. Effect of traditional Japanese garlic preparation on blood pressure in prehypertensive and mildly hypertensive adults. Exp Ther Med 2013;5:399-405.
19. Pekkanen J, Linn S, Heiss G, Suchindran CM, Leon A, Rifkind BM, Tyroler HA. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without pre-existing cardiovascular disease. N Engl J Med 1990;322:1700-7.
20. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256:2823-8.
21. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007;370:1829-39.
22. Zeng T, Guo FF, Zhang CL, Song FY, Zhao XL, Xie KQ. A meta-analysis of randomized, double-blind, placebo-controlled trials for the effects of garlic on serum lipid profiles. J Sci Food Agric 2012;92:1892-902.
23. Reinhart KM, Talati R, White CM, Coleman CI. The impact of garlic on lipid parameters: a systematic review and meta-analysis. Nutr Res Rev 2009;22:39-48.
24. Khoo YS, Aziz Z. Garlic supplementation and serum cholesterol: a meta-analysis. J Clin Pharm Ther 2009;34:133-45.
25. Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA. Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001;161:813-24.
26. Stevinson C, Pittler M, Ernst E. Garlic for treating hypercholesterolemia: a meta-analysis of randomized clinical trials. Ann Intern Med 2000;133:420-9.
27. Silagy C, Neil A. Garlic as a lipid lowering agent-a meta-analysis. J R Coll Physicians Lond 1994;28:39-45.
28. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol: A meta-analysis. Ann Intern Med 1993;119:599-605.
29. Higashikawa F, Noda M, Awaya T, Ushijima M, Sugiyama M. Reduction of serum lipids by the intake of the extract of garlic fermented with Monascus pilosus: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr 2012;31:261-6.
30. Seo DY. Lee S, Figueroa A, Kwak YS, Kim N, Rhee BD, Ko KS, Bang HS, Baek YH, Han J. Independent beneficial effects of aged garlic extract intake with regular exercise on cardiovascular risk in postmenopausal women. Nutr Res Pract 2012;6:226-31.
31. Kumar R, Chhatwal S, Arora S, Sharma S, Singh J, Singh N, Bhandari V, Khurana A. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase-lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes Metab Syndr Obes 2013;6:49-56.
32. Greenland P, Alpert JS, Beller GA, Benjamin EJ, BudoffMJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010;56:e50-103.
33. Waters D, Craven TE, Lespérance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993;87:1067-75.
34. Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 2002;106:1077-82.
35. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMGCoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 1998;339:1972-8.
36. BudoffMJ, Hokanson JE, Nasir K, Shaw LJ, Kinney GL, Chow D, Demoss D, Nuguri V, Nabavi V, Ratakonda R, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging 2010;3:1229-36.
37. Raggi P, Callister TQ, Shaw LJ. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy. Arterioscler Thromb Vasc Biol 2004; 24:1272-7.
38. BudoffMJ, Takasu J, Flores FR, Niihara Y, Lu B, Lau BH, Rosen RT, Amagase H. Inhibiting progression of coronary calcification using Aged Garlic Extract in patients receiving statin therapy: a preliminary study. Prev Med 2004;39:985-91.
39. BudoffMJ, Ahmadi N, Gul KM, Liu ST, Flores FR, Tiano J, Takasu J, Miller E, Tsimikas S. Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial. Prev Med 2009;49: 101-7.
40. Zeb I, Ahmadi N, Nasir K, Kadakia J, Larijani VN, Flores F, Li D, BudoffMJ. Aged garlic extract and coenzyme Q10 have favorable effect on inflammatory markers and coronary atherosclerosis progression: A randomized clinical trial. J Cardiovasc Dis Res 2012;3: 185-90.
41. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 2004;84:277-359.
42. Farmer SR. Molecular determinants of brown adipocyte formation and function. Genes Dev 2008;22:1269-75.
43. Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro-and anti-inflammatory organ. Horm Metab Res 2008;40: 442-5.
44. Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, Rhee SJ, Lee EM, Lee J, Yoo NJ, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007;71:536-9.
45. Ahmadi N, Nabavi V, Hajsadeghi F, Zeb I, Flores F, Ebrahimi R, BudoffM. Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis. Int J Cardiol 2013;168:2310-4.
46. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
47. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87.
48. Larijani VN, Ahmadi N, Zeb I, Khan F, Flores F, BudoffM. Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: the FAITH randomized clinical trial. Nutrition 2013;29:71-5.
49. McPherson R, Frohlich J, Fodor G, Genest J., Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006;22:913-27.
50. Kantor ED, Lampe JW, Vaughan TL, Peters U, Rehm CD, White E. Association between use of specialty dietary supplements and C-reactive protein concentrations. Am J Epidemiol 2012;176:1002-13.
51. van Doorn MB, Espirito Santo SM, Meijer P, Kamerling IM, Schoemaker RC, Dirsch V, Vollmar A, Haffner T, Gebhardt R. Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects. Am J Clin Nutr 2006;84:1324-9.
52. Williams MJ, Sutherland WH, McCormick MP, Yeoman DJ, de Jong SA. Aged garlic extract improves endothelial function in men with coronary artery disease. Phytother Res 2005;19:314-9.
53. Borrelli F, Capasso R, Izzo AA. Garlic (Allium sativum L.): adverse effects and drug interactions in humans. Mol Nutr Food Res 2007; 51:1386-97.
54. Ergül B, Çakal B. Dysphagia caused by garlic induced esophagitis. Clin Res Hepatol Gastroenterol 2012;36:e134.
55. Ma S, Yin J. Anaphylaxis induced by ingestion of raw garlic. Foodborne Pathog Dis 2012;9:773-5.
56. Macan H, Uykimpang R, Alconcel M, Takasu J, Razon R, Amagase H, Niihara Y. Aged garlic extract may be safe for patients on warfarin therapy. J Nutr 2006; 136 (3, Suppl);793S-5S.